Loading

Commentary Open Access
Volume 2 | Issue 4 | DOI: https://doi.org/10.33696/cardiology.2.022

Commentary on: Peptidylglycine alpha-amidating Monooxygenase is Required for Atrial Secretory Granule Formation

  • 1Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
  • 2Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
  • 3Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
  • 4Department of Neuroscience, University of Connecticut Health Center, Farmington CT USA
  • 5Department of Molecular Biology & Biochemistry, University of Connecticut Health Center, Farmington CT USA
+ Affiliations - Affiliations

Corresponding Author

Richard E. Mains, mains@uchc.edu

Received Date: April 19, 2021

Accepted Date: September 24, 2021

Abstract

The electron-dense spherical granules found in the perinuclear region of atrial myocytes store and release both proatrial and probrain natriuretic peptides (proANP and proBNP, respectively). Mature ANP and BNP produce vasodilation and natriuresis and inhibit the renin-angiotensin and sympathetic nervous systems. Although neither ANP nor BNP is a-amidated, Peptidylglycine a-Amidating Monooxygenase (PAM), an integral membrane enzyme known to catalyze the a-amidation of peptidylglycine precursors, is the major atrial granule membrane protein. Selective deletion of PAM from cardiomyocytes impairs their ability to store proANP, resulting in an increase in proANP secretion. Exogenous expression of active or inactive PAM protein restores the ability of atrial myocytes to store proANP, leading to the suggestion that PAM functions as a cargo receptor for newly synthesized proANP.

Author Information X